Why the study?
Do non-cardiac comorbidities and functional impairment predict 12-month all-cause mortality and guideline-directed medical therapy prescription in older adults discharged after acute heart failure hospitalization?
Cohort (n=456)
No
Do non-cardiac comorbidities and functional impairment predict 12-month all-cause mortality and guideline-directed medical therapy prescription in older adults discharged after acute heart failure hospitalization?
Answers are grounded in this paper and cite their sources.
In older patients discharged after acute heart failure hospitalization, non-cardiac comorbidities and functional impairment are nearly universal, independently predict 12-month mortality, and negatively impact guideline-directed medical therapy prescription.
Acute heart failure (AHF) is a leading cause of hospitalization among older adults and is associated with non-cardiac comorbidities (NCCs) and functional impairment. Their prognostic and therapeutic implications remain incompletely characterized. COMPACT-HF was a retrospective cohort study of adults discharged after hospitalization for AHF at a tertiary teaching hospital in 2023. Comorbidity burden was assessed using the age-adjusted Charlson Comorbidity Index (CCI) and predefined NCCs. Functional impairment was defined as loss of ≥ 1 basic activity of daily living (ADL). Primary outcome was 12-month all-cause mortality. We included 456 patients (mean age 82.6 ± 8.6 years; 50% male); 96% had ≥ 1 NCC and 48% had functional impairment. Twelve-month mortality was 31%. CCI was independently associated with mortality (HR 1.17 per point; 95% CI 1.07-1.27, p < 0.001), while functional impairment provided additional prognostic information beyond comorbidity burden. Advanced chronic kidney disease, dementia, and active malignancy were among the NCCs most strongly associated with mortality. Among patients with reduced or mildly reduced ejection fraction, dementia, advanced chronic kidney disease, chronic lung disease, and functional impairment were associated with lower prescription of ≥ 3 of 4 guideline-directed medical therapy (GDMT) classes, whereas CCI was not; GDMT prescription also varied substantially according to discharge ward. In this hospital-wide real-world cohort of patients discharged alive after AHF hospitalization, NCCs and functional impairment were highly prevalent and associated with mortality, while specific clinical conditions and discharge ward were associated with GDMT implementation. Integrating comorbidity and functional assessment may improve risk stratification and support a holistic approach to AHF management.
No takes yet. Share an insight, caveat, or question.
Melchio et al. (2026) conducted a cohort in Acute heart failure (n=456). Non-cardiac comorbidities (assessed by age-adjusted Charlson Comorbidity Index) and functional impairment (loss of ≥1 basic ADL) was evaluated on 12-month all-cause mortality (HR 1.17 per CCI point, 95% CI 1.07-1.27, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: